TC011: Clinical Trials

1 trial of TC011, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow TC011: new trials by email Literature Review of TC011 trials Research Report on TC011

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
TC011 - Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma
Phase 1 / Phase 2RecruitingTICAROS Co., Ltd.982023-08-032026-03-16

Conditions studied

Lymphoma, Large B-Cell, Diffuse (1)

Sponsors

TICAROS Co., Ltd. (1)

Countries

South Korea (1)